Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Circ Res. 2013 Nov 1;114(2):266–282. doi: 10.1161/CIRCRESAHA.113.301720

Figure 6. The spleen influences pathological cardiac remodeling in heart failure (HF).

Figure 6

A, Schema for splenectomy studies in mice with chronic HF. Splenectomy (or sham abdominal surgery) was performed in HF mice 8 weeks after coronary ligation (or sham operation), and remodeling was assessed by echocardiography over an additional 8 weeks. B, M-mode ECGs from 1 mouse at baseline, 8 weeks postligation (HF), and 16 weeks postligation/8 weeks postsplenectomy (HF/splenectomy). C, Quantitative group echocardiographic data for left ventricular (LV) end-diastolic and end-systolic volume (EDV and ESV) and LV ejection fraction (EF) in sham operated and ligated HF mice 8 weeks after splenectomy (n=7 sham mice; n=11 HF mice) or sham abdominal surgery (n=4 HF mice). D. Representative confocal images of CD11b (for macrophages, arrows) and CD11c (for DCs, arrows) immunostained heart sections from HF mice (16 weeks postligation) with or without splenectomy at 8 weeks and corresponding quantification (n=3–4 per group).